Stefani Wolff, Chief Development Officer at Principia Biopharma Inc. (PRNB), sold 7,258 shares at $45.72 ($334K) on 2020-03-16, disclosed to the SEC on 2020-03-18.
Open-market sale of $334k PRNB by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.72 | 1,754 | $80K | 24.0% |
| 2 | $45.72 | 1,754 | $80K | 24.0% |
| 3 | $46.36 | 3,750 | $174K | 52.0% |
| Total | $46.05 avg | 7,258 | $334K | 100% |
| Filing → |
| NRIX | SELL | 2022-11-01 | $5K | — | Filing → |
| NRIX | SELL | 2022-08-02 | $6K | — | Filing → |
| NRIX | SELL | 2022-05-03 | $4K | — | Filing → |